Emre Aldinc

595 total citations
22 papers, 255 citations indexed

About

Emre Aldinc is a scholar working on Molecular Biology, Genetics and Cell Biology. According to data from OpenAlex, Emre Aldinc has authored 22 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Cell Biology. Recurrent topics in Emre Aldinc's work include Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers), Dermatological and Skeletal Disorders (7 papers) and Skin and Cellular Biology Research (5 papers). Emre Aldinc is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers), Dermatological and Skeletal Disorders (7 papers) and Skin and Cellular Biology Research (5 papers). Emre Aldinc collaborates with scholars based in United States, Japan and United Kingdom. Emre Aldinc's co-authors include David Adams, Michael Polydefkis, Simina Ticau, Paul Nioi, David V. Erbe, Amy Chan, Kevin Fitzgerald, Gautham Sridharan, Mary M. Reilly and Jason A. Gilbert and has published in prestigious journals such as Journal of the American College of Cardiology, Neurology and European Journal of Heart Failure.

In The Last Decade

Emre Aldinc

19 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emre Aldinc United States 10 161 53 53 48 43 22 255
Marie‐Laure Martin‐Négrier France 12 178 1.1× 85 1.6× 51 1.0× 30 0.6× 22 0.5× 22 305
Weiyue Gu China 11 139 0.9× 21 0.4× 47 0.9× 17 0.4× 101 2.3× 50 317
Arum Oh South Korea 7 109 0.7× 46 0.9× 38 0.7× 30 0.6× 91 2.1× 18 247
Stayko Sarafov Bulgaria 9 215 1.3× 68 1.3× 41 0.8× 37 0.8× 68 1.6× 20 297
Yusaku Shimizu Japan 8 203 1.3× 51 1.0× 37 0.7× 22 0.5× 31 0.7× 21 266
Valeria Guglielmino Italy 7 122 0.8× 9 0.2× 26 0.5× 37 0.8× 33 0.8× 27 178
Cécile Cauquil France 9 150 0.9× 69 1.3× 29 0.5× 46 1.0× 28 0.7× 20 268
Tianming Liu China 4 166 1.0× 9 0.2× 30 0.6× 30 0.6× 76 1.8× 11 363
Claudia Stancanelli Italy 10 251 1.6× 28 0.5× 32 0.6× 61 1.3× 51 1.2× 17 314
Carlos E. Speck‐Martins Brazil 11 137 0.9× 27 0.5× 25 0.5× 20 0.4× 58 1.3× 23 314

Countries citing papers authored by Emre Aldinc

Since Specialization
Citations

This map shows the geographic impact of Emre Aldinc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emre Aldinc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emre Aldinc more than expected).

Fields of papers citing papers by Emre Aldinc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emre Aldinc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emre Aldinc. The network helps show where Emre Aldinc may publish in the future.

Co-authorship network of co-authors of Emre Aldinc

This figure shows the co-authorship network connecting the top 25 collaborators of Emre Aldinc. A scholar is included among the top collaborators of Emre Aldinc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emre Aldinc. Emre Aldinc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miao, Zi Michael, Brian Claggett, Pablo García‐Pavía, et al.. (2025). Efficacy and Safety of Vutrisiran in Transthyretin Amyloid Cardiomyopathy Across the Age Spectrum: The HELIOS-B Trial. European Journal of Heart Failure. 27(12). 2971–2978.
2.
Maurer, Matthew J., Ronald Witteles, Pablo García‐Pavía, et al.. (2025). Impact of Heart Failure Severity on Vutrisiran Efficacy in Transthyretin Amyloidosis With Cardiomyopathy. Journal of the American College of Cardiology. 85(20). 1927–1939. 1 indexed citations
3.
Sheikh, Farooq H., Gilbert Habib, W.H. Wilson Tang, et al.. (2025). Impact of Vutrisiran on Functional Capacity and Quality of Life in Transthyretin Amyloidosis With Cardiomyopathy. Journal of the American College of Cardiology. 85(20). 1943–1955. 3 indexed citations
4.
Luigetti, Marco, Dianna Quan, John L. Berk, et al.. (2024). Impact of Baseline Neuropathy Severity on Vutrisiran Treatment Response in the Phase 3 HELIOS-A Study. Neurology and Therapy. 13(3). 625–639. 2 indexed citations
5.
Maurer, Matthew J., Julian D. Gillmore, Shaun Bender, et al.. (2024). Outpatient Worsening Heart Failure in Patients With Transthyretin Amyloidosis With Cardiomyopathy in the HELIOS-B Trial. Journal of the American College of Cardiology. 85(7). 753–761. 11 indexed citations
6.
Aldinc, Emre, et al.. (2023). Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review. BMC Musculoskeletal Disorders. 24(1). 751–751. 10 indexed citations
7.
Aldinc, Emre, Simina Ticau, Michael Polydefkis, et al.. (2023). NfL levels significantly decrease in response to treatment with patisiran or vutrisiran in hATTR amyloidosis with polyneuropathy. 62–62. 3 indexed citations
8.
Mochizuki, Yusuke, Yusuke Takahashi, Emre Aldinc, et al.. (2023). Neurofilament light chain as a biomarker for monitoring response to change in treatment in hereditary ATTR amyloidosis. Amyloid. 30(3). 351–352. 11 indexed citations
9.
10.
Quan, Dianna, Laura Obici, John L. Berk, et al.. (2022). Impact of baseline polyneuropathy severity on patisiran treatment outcomes in the APOLLO trial. Amyloid. 30(1). 49–58. 13 indexed citations
11.
Polydefkis, Michael, Simina Ticau, David V. Erbe, et al.. (2021). Neurofilament Light Chain (NfL) as a Potential Biomarker of Treatment Response in Hereditary Transthyretin-Mediated Amyloidosis: Data from the Patisiran Global OLE Study (1291). Neurology. 96(15_supplement). 1 indexed citations
12.
13.
Ticau, Simina, Gautham Sridharan, William Cantley, et al.. (2020). Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis. Neurology. 96(3). e412–e422. 72 indexed citations
14.
Ticau, Simina, Gautham Sridharan, William Cantley, et al.. (2020). Neurofilament Light Chain may Serve As a Biomarker of Neuropathy in Hattr Amyloidosis with Cardiomyopathy. Journal of Cardiac Failure. 26(10). S96–S96. 2 indexed citations
15.
Parker, Margaret M., Simina Ticau, James Butler, et al.. (2020). Transthyretin-stabilising mutation T119M is not associated with protection against vascular disease or death in the UK Biobank. Amyloid. 27(3). 184–190. 5 indexed citations
16.
González‐Duarte, Alejandra, John L. Berk, Dianna Quan, et al.. (2019). Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis. Journal of Neurology. 267(3). 703–712. 42 indexed citations
17.
Malik, Rayaz A., Emre Aldinc, Chaicharn Deerochanawong, et al.. (2017). Perceptions of Painful Diabetic Peripheral Neuropathy in South-East Asia: Results from Patient and Physician Surveys. Advances in Therapy. 34(6). 1426–1437. 34 indexed citations
18.
Damjanov, Nemanja, Sarolta Kárpáti, Lajos Kemény, et al.. (2017). Efficacy and safety of etanercept in psoriasis and psoriatic arthritis in the PRESTA study: analysis in patients from Central and Eastern Europe. Journal of Dermatological Treatment. 29(1). 8–12. 9 indexed citations
19.
Kemény, Lajos, Petra Cetkovská, Natta Rajatanavin, et al.. (2015). Effect of etanercept therapy on psoriasis symptoms in patients from Latin America, Central Europe, and Asia: a subset analysis of the PRISTINE trial. BMC Dermatology. 15(1). 9–9. 6 indexed citations
20.
Atakan, Nilgün, Ayça Cordan Yazıcı, Güzin Özarmağan, et al.. (2015). TUR‐PSO: A cross‐sectional, study investigating quality of life and treatment status of psoriasis patients in Turkey. The Journal of Dermatology. 43(3). 298–304. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie‐Laure Martin‐Négrier Breakdown of academic impact, for papers by Weiyue Gu Breakdown of academic impact, for papers by Arum Oh Breakdown of academic impact, for papers by Stayko Sarafov Breakdown of academic impact, for papers by Yusaku Shimizu Breakdown of academic impact, for papers by Valeria Guglielmino Breakdown of academic impact, for papers by Cécile Cauquil Breakdown of academic impact, for papers by Tianming Liu Breakdown of academic impact, for papers by Claudia Stancanelli Breakdown of academic impact, for papers by Carlos E. Speck‐Martins
Rankless by CCL
2026